Zidoval
Zidoval vaginal gel is indicated for the treatment of bacterial vaginosis.
Zidoval vaginal gel is indicated for the treatment of bacterial vaginosis.
Antiprotozoal-antibacterials - ATC classification: G01AF01
Metronidazole 0.75% w/w, 7.5 mg/g
Metronidazole
Vaginal gel A colourless to straw coloured gel
19 November 2012
For vaginal administration.
Adults
One application of Zidoval vaginal gel (5g) inserted into the vagina once daily, at bedtime, for 5 consecutive days.
Directions for use: Pierce sealed end of tube and screw open end of applicator tightly onto tube of gel. Squeeze tube, filling the applicator with gel. Remove applicator from tube and gently insert applicator into vagina as far as it will comfortably go. Push the plunger to release the gel. Dispose of applicator as instructed.
Elderly
Bacterial vaginosis is not commonly seen in the elderly population and consequently clinical assessment in this age group has not been carried out.
Children
Not recommended for use in children and adolescents under 18 years since safety and efficacy have not been established.
Use during menses is not recommended.
Known or previously unrecognised candidiasis may present more prominent symptoms during therapy with Zidoval vaginal gel and may require treatment with a candicidal agent.
Metronidazole is a nitroimidazole and should be used with care in patients with evidence of a history of blood dyscrasias.
As with all vaginal infections, sexual intercourse during the infection and during treatment with Zidoval vaginal gel is not recommended.
In controlled clinical trials involving 759 patients, the most commonly reported ADRs were urogenital (26%) and gastrointestinal (14%).
|
Infections and infestations |
|
|
Common (≥1/100, <1/10): |
Vaginal candidiasis. |
|
Metabolism and nutrition disorders |
|
|
Common (≥1/100, <1/10): |
Decreased appetite |
|
Psychiatric Disorders |
|
|
Uncommon (≥1/1000, <1/100): |
Depression, difficulty sleeping. |
|
Nervous system disorders |
|
|
Common (≥1/100, <1/10): |
Headache, dizziness. |
|
Uncommon (≥1/1000, <1/100): |
Abnormal sensation of limbs, metallic taste. |
|
Gastrointestinal disorders |
|
|
Common (≥1/100, <1/10): |
GI discomfort/abdominal cramps, nausea and/or vomiting, unpleasant taste/unusual feeling on tongue. |
|
Uncommon (≥1/1000, <1/100): |
Diarrhoea, constipation, abdominal bloating/noises, dry mouth. |
|
Skin and subcutaneous tissue disorders |
|
|
Uncommon (≥1/1000, <1/100): |
Itching. |
|
Musculoskeletal and connective tissue disorders |
|
|
Uncommon (≥1/1000, <1/100): |
Cramp. |
|
Renal and Urinary disorders |
|
|
Uncommon (≥1/1000, <1/100): |
Urine discolouration, urinary tract infection symptoms. |
|
Reproductive system and breast disorders |
|
|
Common (≥1/100, <1/10): |
Vaginal itching/irritation/burning/numbness, pelvic discomfort, vaginal discharge. |
|
Uncommon (≥1/1000, <1/100): |
Oedema vulva, menstrual discomfort/irregularities, vaginal spotting/bleeding. |
|
General disorders and administration site conditions |
|
|
Uncommon (≥1/1000, <1/100): |
Fatigue, irritability. |
Zidoval vaginal gel is contraindicated in patients with a prior history of hypersensitivity to metronidazole, other nitroimidazoles, parabens or any other ingredient of the gel.